Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions
Authors:
- K. StrydomKSK. Strydom
- Zelda WilliamsZWZelda Williams
- Louis VenterLVLouis Venter
- Stefan LeichtlSLStefan Leichtl
- Christine Schmid-WirlitschCSChristine Schmid-Wirlitsch
- Dirk BredenbrökerDBDirk Bredenbröker
- Philip G. BardinPBPhilip G. Bardin
- 1 August 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 116 (2) , 292-298